Citation Impact

Citing Papers

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol
2011 Standout
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Hepatocellular carcinoma
2003 Standout
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Functional Gastroduodenal Disorders
2006 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Silent Peptic Ulceration: Deadly Silence or Golden Silence?
1989
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis
1990
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Cost-effectiveness Analysis of a Two-stage Screening Intervention for Hepatocellular Carcinoma in Taiwan
2010
The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country
2001
Hepatocellular Cancer: A Guide for the Internist
2007
Screening for hepatocellular carcinoma
1998
Screening for hepatocellular carcinoma
1999
Hepatitis B virus infection
2009 Standout
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
Chronic hepatitis B
2001
Screening for hepatocellular carcinoma
2005
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Acid-Sensitive Ion Channels and Receptors
2009
The long‐term effect of treatment with interferon‐α2a in chronic hepatitis B
1998
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Hepatitis B vaccines
2003
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Ulcerative colitis in a multiracial Asian country: Racial differences and clinical presentation among Malaysian patients
2005
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
2000 Standout
Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey
2010
Management of Hepatocellular Carcinoma *
2005 Standout
Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B
1996
Long-term follow-up of chronic hepatitis B patients treated with interferon alfa
1993
Racial differences in Helicobacter pylori seroprevalence in Singapore: Correlation with differences in peptic ulcer frequency
1997
Incidence and prevalence of ulcerative colitis in Punjab, North India
2003
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Crohn's disease
2016 Standout
Racial differences in the prevalence of ulcerative colitis and Crohn’s disease in Singapore
2000
Basic and clinical aspects of visceral hyperalgesia
1994
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
The Epidemiology and Phenotype of Crohn’s Disease in the Chinese Population
2004
Chronic hepatitis B
2007 Standout
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
1992
Capsaicin as an inhibitor of the growth of the gastric pathogen Helicobacter pylori
2006
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
1998
Review article: functional dyspepsia—should treatment be targeted on disturbed physiology?
1995
T-lymphocyte response to hepatitis C virus in different clinical courses of infection
1993 StandoutNobel
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Ulcerative colitis
2016 Standout
Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system
2011
Ulcerative Colitis in Kuwait: A Review of 90 Cases
2003
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Treatment of hepatitis
1988
Clinical economics review: irritable bowel syndrome
1997
Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy
2000
Helicobacter pyloriInfection
2002 Standout
Stress and animal models of inflammatory bowel disease—An update on the role of the hypothalamo–pituitary–adrenal axis
2011
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.
1998
Long–Term Follow–Up of Interferon Alfa Treatment in Chinese Patients With Chronic Hepatitis B Infection: the Effect on Hepatitis B E Antigen Seroconversion and the Development of Cirrhosis–Related Complications
2001
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Bleeding Peptic Ulcer
1994 Standout
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
1991
Alpha interferon therapy in the treatment of idiopathic thrombocytopenic purpura
1991
Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: Experience from a single center in Hong Kong
2007
Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B
1996
Cost‐effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C
2004
Prednisone-interferon combination in the treatment of chronic hepatitis B: Direct and indirect metanalysis
1994
Helicobacter pylori and gastrointestinal tract adenocarcinomas
2002
α‐interferon therapy for severe chronic idiopathic thrombocytopenic purpura in children
1993
The human microbiome: at the interface of health and disease
2012 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Gene Therapy for Infectious Diseases
1998
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
TRP Channels and Pain
2013 StandoutNobel
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2b
1993 StandoutNobel
Plant Products as Antimicrobial Agents
1999 Standout
Splicing Diversity of the Human OCLN Gene and Its Biological Significance for Hepatitis C Virus Entry
2010 StandoutNobel
Which Patients With Chronic Hepatitis B Virus Infection Will Respond to α–Interferon Therapy? A Statistical Analysis of Predictive Factors
1989
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
BLEEDING PEPTIC ULCER: SURGICAL THERAPY
1993
Racial differences in responses to therapy with interferon in chronic hepatitis C
1999
Surveillance for hepatocellular carcinoma
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Treatment of Chronic Viral Hepatitis
1998
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Interferon-α for HBeAg-positive chronic hepatitis B
2003
Treatment of Chronic Viral Hepatitis
2001
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout

Works of I. Yap being referenced

Helicobacter pylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: ethnic differences in Singapore.
1990
Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.
1989
Acid perfusion of duodenal ulcer craters and ulcer pain: a controlled double blind study.
1986
The pattern of functional and organic disorders in an Asian gastroenterological clinic
1994
Analysis of cost‐effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers
1992
Low Frequency of Endoscopic Esophagitis in Asian Patients
1993
Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre‐S components of the HBV coat protein with non pre‐S containing vaccines
1995
Treatment of thrombocytopenia with alfa interferon.
1987
Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein—a preliminary study on immunogenicity
1992
Acid and Gastric Ulcer Pain
1991
Chili protects against aspirin-induced gastroduodenal mucosal injury in humans
1995
Inflammatory bowel disease: An uncommon problem in Singapore
1992
Chili—Protective factor against peptic ulcer?
1995
A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the royal free hospital studies of hepatitis B virus carrier treatment: Identification of factors influencing response rates
1987
Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study.
1990
Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection
1986
Influence of the site of a duodenal ulcer on its mode of presentation
1986
Racial differences in peptic ulcer frequency in Singapore
1987
Rankless by CCL
2026